851 related articles for article (PubMed ID: 17337757)
1. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
[TBL] [Abstract][Full Text] [Related]
2. Risk of breast cancer in post-menopausal women using hormone replacement therapy.
Ratanawichitrasin A; Reansuwan W; Ratanawichitrasin S; Bhodhisuwan K; Kongpatanakul S
J Med Assoc Thai; 2002 May; 85(5):583-9. PubMed ID: 12188389
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
Olsson HL; Ingvar C; Bladström A
Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
[TBL] [Abstract][Full Text] [Related]
4. Menstrual factors in relation to breast cancer risk.
Titus-Ernstoff L; Longnecker MP; Newcomb PA; Dain B; Greenberg ER; Mittendorf R; Stampfer M; Willett W
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):783-9. PubMed ID: 9752986
[TBL] [Abstract][Full Text] [Related]
5. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Marchbanks PA; Coates RJ; Norman SA; Weiss LK; Ursin G; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Spirtas R
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277
[TBL] [Abstract][Full Text] [Related]
6. Reproductive factors and breast cancer risk among older women.
Shantakumar S; Terry MB; Teitelbaum SL; Britton JA; Millikan RC; Moorman PG; Neugut AI; Gammon MD
Breast Cancer Res Treat; 2007 May; 102(3):365-74. PubMed ID: 17033925
[TBL] [Abstract][Full Text] [Related]
7. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS
Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149
[TBL] [Abstract][Full Text] [Related]
8. [Replacement therapy in menopause and risk for breast tumors].
Franceschi S
Ann Ist Super Sanita; 1997; 33(2):207-11. PubMed ID: 9470242
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement treatment and breast cancer risk: an age-specific analysis.
Tavani A; Braga C; La Vecchia C; Negri E; Franceschi S
Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):11-4. PubMed ID: 8993791
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy use and variations in the risk of breast cancer.
Opatrny L; Dell'Aniello S; Assouline S; Suissa S
BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for pituitary tumors: a case-control study.
Schoemaker MJ; Swerdlow AJ
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1492-500. PubMed ID: 19423526
[TBL] [Abstract][Full Text] [Related]
13. Hormonal and reproductive factors and the risk of bladder cancer in women.
McGrath M; Michaud DS; De Vivo I
Am J Epidemiol; 2006 Feb; 163(3):236-44. PubMed ID: 16319290
[TBL] [Abstract][Full Text] [Related]
14. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
Tzingounis V; Cardamakis E; Ginopoulos P; Argiropoulos G
Anticancer Res; 1996; 16(6C):3997-4000. PubMed ID: 9042326
[TBL] [Abstract][Full Text] [Related]
15. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
[TBL] [Abstract][Full Text] [Related]
16. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer risk in the WHI study: the problem of obesity.
Kuhl H
Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
[TBL] [Abstract][Full Text] [Related]
18. Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based case-control study.
Galanti MR; Hansson L; Lund E; Bergström R; Grimelius L; Stalsberg H; Carlsen E; Baron JA; Persson I; Ekbom A
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):425-31. PubMed ID: 8781737
[TBL] [Abstract][Full Text] [Related]
19. Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: findings from the canadian national enhanced cancer surveillance system.
Frise S; Kreiger N; Gallinger S; Tomlinson G; Cotterchio M
Ann Epidemiol; 2006 Dec; 16(12):908-16. PubMed ID: 16843679
[TBL] [Abstract][Full Text] [Related]
20. Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York.
Eng SM; Gammon MD; Terry MB; Kushi LH; Teitelbaum SL; Britton JA; Neugut AI
Am J Epidemiol; 2005 Aug; 162(3):229-37. PubMed ID: 15987723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]